Analysis of serum phospholipid profiles by liquid chromatography-tandem mass spectrometry in high resolution mode for evaluation of atherosclerotic patients

Journal of Chromatography A

Volumn 1371, Issue , 2014, Pages 154-162

  Calderon Santiago M ^a   Priego Capote, F ^a   Galache Osuna, J G ^b   Luque de Castro, M D ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Atherosclerosis; Human serum; LC QTOF MS MS; Metabolomics; Phospholipids

Indexed keywords

CARDIOLOGY; DISEASES; ECONOMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MULTIVARIANT ANALYSIS; PATIENT MONITORING; PHASE SEPARATION; PHOSPHOLIPIDS;

ATHEROSCLEROSIS; HUMAN SERUM; LC-QTOF-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; METABOLOMICS; PREDICTION CAPABILITY; SELECTIVE SOLID-PHASE EXTRACTION; ST-ELEVATION MYOCARDIAL INFARCTIONS;

DIAGNOSIS;

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHOLIPID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PHOSPHOLIPID BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STABLE ANGINA PECTORIS; TANDEM MASS SPECTROMETRY; UNSTABLE ANGINA PECTORIS; VERY ELDERLY; ANGINA PECTORIS; BLOOD; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; PROCEDURES; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOSPHOLIPIDS; RISK FACTORS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84918562030     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.10.052     Document Type: Article

References (33)

1. Petersen S., Peto V., Rayner M., Leal J., Luengo-Fernández R., Gray A. European Cardiovascular Disease Statistics, London, UK 2005.
2. Rimmerman C.M. Coronary artery disease. Clevel. Clin. Curr. Clin. Med. Expert Consult 2010, 1376. Elsevier Health Sciences. W.D. Carey (Ed.).
3. Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000, 284:835-842.
4. Barderas M.G., Laborde C.M., Posada M., de la Cuesta F., Zubiri I., Vivanco F., et al. Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases. J. Biomed. Biotechnol. 2011, 2011:790132.
5. Wang K., Asinger R.W., Marriott H.J.L. ST-segment elevation in conditions other than acute myocardial infarction. N. Engl. J. Med. 2003, 349:2128-2135.
6. Mahley R.W., Innerarity T.L., Rall S.C., Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 1984, 25:1277-1294.
7. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986, 256:2835-2838.
8. Tu A.Y., Nishida H.I., Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 1993, 268:23098-23105.
9. Wolfbauer G., Albers J.J., Oram J.F. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1999, 1439:65-76.
10. Bagdade J.D., Buchanan W.F., Pollare T., Lithell H. Abnormal lipoprotein phospholipid composition in patients with essential hypertension. Atherosclerosis 1995, 117:209-215.
11. Xia P., Vadas M.A., Rye K.-A., Barter P.J., Gamble J.R. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway: a possible mechanism for protection against atherosclerosis by HDL. J. Biol. Chem. 1999, 274:33143-33147.
12. Ibdah J.A., Lund-Katz S., Phillips M.C. Molecular packing of high-density and low-density lipoprotein surface lipids and apolipoprotein A-I binding. Biochemistry 1989, 28:1126-1133.
13. Hu C., van der Heijden R., Wang M., van der Greef J., Hankemeier T., Xu G. Analytical strategies in lipidomics and applications in disease biomarker discovery. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2009, 877:2836-2846.
14. Houjou T., Yamatani K., Imagawa M., Shimizu T., Taguchi R. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19:654-666.
15. Kosicek M., Kirsch S., Bene R., Trkanjec Z., Titlic M., Bindila L., et al. Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients - a pilot study. Anal. Bioanal. Chem. 2010, 398:2929-2937.
16. Yan X., Li H., Xu J., Zhou C. Analysis of phospholipids in microalga Nitzschia closterium by UPLC-Q-TOF-MS. Chin. J. Oceanol. Limnol. 2010, 28:106-112.
17. Guan X.L., Wenk M.R. Mass spectrometry-based profiling of phospholipids and sphingolipids in extracts from Saccharomyces cerevisiae. Yeast 2006, 23:465-477.
18. She Y., Song J., Yang E., Zhao L., Zhong Y., Rui W., et al. Rapid identification of glycerophospholipids from RAW264.7 cells by UPLC/ESI-QTOF-MS. Biomed. Chromatogr. 2014, 10.1002/bmc.3216.
19. Trabelsi H., Renaud J., Herchi W., Khouja M.L., Boukhchina S., Mayer P. LC-ESI-QTOF-MS, MS/MS analysis of glycerophospholipid species in three Tunisian Pistacia lentiscus fruit populations. J. Am. Oil Chem. Soc. 2013, 90:611-618.
20. Choi J.M., Kim T.-E., Cho J.-Y., Lee H.J., Jung B.H. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2014, 944:157-165.
21. Knittelfelder O.L., Weberhofer B.P., Eichmann T.O., Kohlwein S.D., Rechberger G.N. A versatile ultra-high performance LC-MS method for lipid profiling. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2014, 951-952:119-128.
22. Timperio A.M., Mirasole C., D'Alessandro A., Zolla L. Red blood cell lipidomics analysis through HPLC-ESI-qTOF: application to red blood cell storage. J. Integr. OMICS 2013, 3.
23. Cui L., Lee Y.H., Kumar Y., Xu F., Lu K., Ooi E.E., et al. Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl. Trop. Dis. 2013, 7:e2373.
24. Xia J., Broadhurst D.I., Wilson M., Wishart D.S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 2013, 9:280-299.
25. Pulfer M., Murphy R.C. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 2013, 22:332-364.
26. Gürdeniz G., Rago D., Bendsen N.T., Savorani F., Astrup A., Dragsted L.O. Effect of trans fatty acid intake on LC-MS and NMR plasma profiles. PLOS ONE 2013, 8:e69589.
27. Jezková J., Nováková O., Kolár F., Tvrzická E., Neckár J., Novák F. Chronic hypoxia alters fatty acid composition of phospholipids in right and left ventricular myocardium. Mol. Cell. Biochem. 2002, 232:49-56.
28. 2+-independent PLA2 in hypoxic ventricular myocytes. Am. J. Physiol. 1998, 274:C1727-C1737.
29. Schaefer C.A., Kuhlmann C.R.W., Gast C., Weiterer S., Li F., Most A.K., et al. Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholine-induced proliferation of human endothelial cells. Vascul. Pharmacol. 2004, 41:67-73.
30. Fernandez C., Sandin M., Sampaio J.L., Almgren P., Narkiewicz K., Hoffmann M., et al. Plasma lipid composition and risk of developing cardiovascular disease. PLOS ONE 2013, 8:e71846.
31. Hung N.D., Sok D.-E., Kim M.R. Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine. Inflamm. Res. Off. J. Eur. Histamine Res. Soc. 2012, 61:473-483.
32. Jiang X.C., Paultre F., Pearson T.A., Reed R.G., Francis C.K., Lin M., et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2614-2618.
33. Shiratori Y., Houweling M., Zha X., Tabas I. Stimulation of CTP:phosphocholine cytidylyltransferase by free cholesterol loading of macrophages involves signaling through protein dephosphorylation. J. Biol. Chem. 1995, 270:29894-29903.